Background
==========

Brachydactyly type E (BDE; MIM\#113300) is characterized by shortening of the metacarpal, metatarsal, and often phalangeal bones, and predominantly affects postaxial ray(s) of the limb \[[@B1]\]. In most cases BDE is syndromic and occurs within the clinical spectrum of Turner syndrome, Albright hereditary osteodystrophy (AHO; MIM\#103580) or 2q37 deletion \[[@B1]\]. Isolated BDE is rare and in the majority of cases has unknown genetic background. Originally, the molecular cause of isolated BDE has been unravelled in 2 families and shown to result from heterozygous missense mutations in the homeodomain of the *HOXD13*gene \[[@B2]\]. Some patients from these families presented not only with BDE, but also with overlapping features of brachydactyly type D (BDD), defined as shortening and broadening of the thumbs \[[@B2]\].

Missense variants affecting other residues of the C-terminal HOXD13 homeodomain may also give rise to different and more severe limb phenotypes such as synpolydactyly (SPD; MIM\#186000) or syndactyly type 5 (MIM\#186300), whereas expansion or contraction of the N-terminal HOXD13 polyalanine tract usually results in SPD \[[@B3]-[@B6]\]. Most patients affected by SPD show fusion of third and fourth fingers and fourth and fifth toes, accompanied with incomplete or complete insertional polydactyly within the syndactylous web. Affected individuals may also have external rotation of fifth toes, clinodactyly, and camptodactyly (Figure [1H, I](#F1){ref-type="fig"} &[1J](#F1){ref-type="fig"} present a family with classical SPD caused by insertion of 7 alanines within the HOXD13 polyalanine tract). The clinical presentation of SPD is highly heterogeneous and varies within the affected individual (asymmetrical expressivity) or in the family. Severe manifestation and incomplete penetrance may occur within the same pedigree \[[@B4],[@B5]\].

![**A-Brachydactyly type E (BDE) in the proband characterized by shortened V^th^fingers, B, C-Clinical picture of BDE (shortened V^th^fingers and toes) in the proband\'s father, D-X-ray of the proband\'s hands showing shortening of the V^th^right metacarpal, bilateral shortening and broadening of the I^st^metacarpals, and bilateral shortening of the middle phalanges of V^th^fingers (skeletal abnormalities are indicated by the white arrows), E-Feet of the proband showing broad halluces and no clinically evident BDE, F-Pedigree of the presented BDE family (proband is indicated by an arrow), G-Chromatogram picture showing the c.820C \> T(p.R274X) *HOXD13*mutation**. Wild-type HOXD13 protein sequence is presented in blue, whereas truncated protein variant is shown in red. **H**- Hand malformation typical for synpolydactyly (SPD) spectrum (syndactyly of fingers 3/4 with insertional polydactyly within the syndactylous web), **I**- Typical SPD foot malformation characterized by syndactyly of 4/5 toes, **J**- External rotation of 5^th^toe often seen in SPD patients (SPD in patients shown in pictures H, I, J results from insertions of 7 Ala in the polyalanine tract).](1471-2350-13-4-1){#F1}

*HOXD13*is a member of a large family of developmental homeobox transcription factor genes. Human, as well as other vertebrate genomes contain 39 *HOX*genes organized into four clusters (*HOXA, HOXB, HOXC*, and *HOXD*). *HOX*genes are involved in body plan formation and embryonic development of many internal organs, such as central nervous system, gastrointestinal and genitourinary tract. They also play a critical role in limb development by influencing limb patterning along proximodistal and anteroposterior axes. In general, the position of the gene in each cluster corresponds to its spatio-temporal expression during limb development in an order from 3\' to 5\' end. Thus, homologues located at the 3\' end of the cluster are expressed earlier in development and in more proximal and anterior structures, whereas those located at the 5\' end are expressed later and in more posterior and distal embryonic regions \[[@B7],[@B8]\]. The *HOXD13*gene consists of two exons and encodes a protein built of 335 amino acids. Exon 1 contains an N-terminal tract comprised of 15 polyalanine residues in wild-type protein. Exon 2 carries a sequence for a highly conserved C-terminal DNA binding domain, known as homeodomain, through which HOXD13 interacts with consensus DNA sequence. A schematic view of the protein structure and a summary of annotated mutations are given in Figure [2](#F2){ref-type="fig"}.

![**Schematic presentation of the *HOXD13*gene structure and overview of all annotated *HOXD13*mutations identified in patients affected by various limb malformations**. Arrows indicate approximate positions of *HOXD13*mutations. Numbers below or above each arrow refer to specific mutations and correspond to the numbers provided in the table below. Different designations have been used to discriminate between types of mutations: arrows above the exons indicate mutations causing BDE, BD-syndactyly, and syndactyly type V (white, grey, and black arrows respectively); arrows below the exons show mutations resulting in SPD or unspecified limb phenotype (black and grey arrows respectively). Mutation p.R274X identified in our proband (number 18) has been bolded and highlighted with large arrow.](1471-2350-13-4-2){#F2}

Recently, Klopocki et al. \[[@B9]\] described causative alterations (microdeletion and point mutations) in the *PTHLH*gene in five unrelated families affected by BDE and short stature. Since the initial paper of Johnson et al. from 2003 \[[@B2]\], *HOXD13*mutation has been reported only in a single family manifesting isolated BDE \[[@B10]\]. In addition, only 8 out of 24 annotated *HOXD13*mutations resulted in a premature termination of the protein synthesis \[[@B10]-[@B17]\]; see Figure [2](#F2){ref-type="fig"}). Thus, genotype-phenotype correlation for truncating HOXD13 variants remains poorly known.

In this paper, we relate on a Polish family exhibiting isolated BDE caused by a nonsense heterozygous *HOXD13*mutation and refer our clinical and molecular finding to previously described *HOXD13*associated phenotypes and mutations.

Case presentation
-----------------

We investigated a 10 year old female proband and her 28 year old father of Polish origin, both affected by isolated BDE (a family tree is shown in Figure [1F](#F1){ref-type="fig"}). Skeletal manifestations of the proband (Figure [1A, D](#F1){ref-type="fig"} &[1E](#F1){ref-type="fig"}) comprised shortening of the V^th^right metacarpal without shortening of IV^th^metacarpal bones, bilateral shortening and broadening of the I^st^metacarpals, bilateral shortened, trapezoid middle phalanges of V^th^fingers resulting in rather severe clinodactyly, as well as contractures and deviations of the fingers II-IV. Upon clinical examination feet of the proband showed broad halluces and no clinically recognizable BDE phenotype. Unfortunately, since no X-ray was available, we were unable to rule out all possible skeletal foot abnormalities. The proband\'s father (Figure [1B](#F1){ref-type="fig"} &[1C](#F1){ref-type="fig"}) manifested finger contractures, shortening of the V^th^fingers and toes most probably due to shortened V^th^metacarpals and metatarsal, shortened finger nails of the V^th^fingers most likely resulting from hypoplastic distal phalanges, as well as short thumbs. Unfortunately, the patient decided not to undergo X-ray examination, thus we were unable to delineate skeletal findings in more detail. Both patients had normal stature and normal psychomotor development.

Genomic DNA was extracted from peripheral blood leukocytes according to salting-out method \[[@B18]\]. The entire coding sequence of the *HOXD13*gene comprised of two exons and the flanking intronic regions (GenBank [NM_000523.3](NM_000523.3)) were amplified in PCR reactions and directly sequenced using dye-terminator chemistry (kit v.3, ABI 3130XL). Sequences of the primers used for amplification and sequencing PCR reactions are given in table [1](#T1){ref-type="table"}. PCR conditions used for *HOXD13*amplification where as follows: 40 cycles, denaturation in 95°C (30\'), annealing (30\') with temperature starting from 63°C, decreasing to 55°C (touchdown PCR -0.2°C per cycle), and elongation in 72°C (45\'). Multiplex ligation-dependent probe amplification (MLPA) for both exons of the *HOXD13*was performed by means of P179 commercial kit according to the manufacturer\'s protocol (MRC Holland).

###### 

Sequences of the primers used for *HOXD13*gene amplification and sequencing.

  ----------------------------------------------------------------------------------------------------
  Exon name\     Forward primer sequence 5\'- 3\'   Reverse primer sequence 5\'- 3\'   Product size\
  (fragment)                                                                           (bp)
  -------------- ---------------------------------- ---------------------------------- ---------------
  HOXD13_e1(a)   TATAAACGTCCCGCGATGAG               ATTCTGCTGTAAGCCCACGC               644

                                                                                       

  HOXD13_e1(b)   CAAAGAGTGCCCAGCACC                 TAACCCTGGTCACGTGTGG                599

                                                                                       

  HOXD13_e2      AAAATTTCCTGCACCCCTG                CACAAAATTTGCCACCATTG               491
  ----------------------------------------------------------------------------------------------------

The proband and her father carried a nonsense heterozygous mutation c.820C \> T(p.R274X) in the *HOXD13*gene (Figure [1G](#F1){ref-type="fig"}). Presence of this mutation was excluded in 208 ethnically matched control chromosomes. MLPA ruled out intragenic copy number changes within the *HOXD13*in both proband and her father (i.e. deletion/duplication).

Discussion
==========

So far, only a few *HOXD13*mutations are known to result in an isolated brachydactyly phenotype \[[@B2],[@B10]\]. Originally, two missense mutations (p.S308C and p.I314L), localized within the homeodomain of the HOXD13 transcription factor were associated with overlapping features of BDE and BDD \[[@B2]\]. Both changes were supposed to alter DNA binding affinity of the protein \[[@B2]\]. Additionally, one nonsense variant p.E181X was described by Brison et al. \[[@B10]\] in a Belgian family presenting with isolated BDE, but neither detailed clinical description nor pictures were provided for this case. The variant p.R274X identified in our proband and her father is the fourth *HOXD13*mutation, and the second truncating (nonsense) mutation reported to result in typical isolated BDE/BDD. Noteworthy, clinical manifestation of BDE in our patients shared significant similarities with the features reported by Johnson et al. \[[@B2]\] in the two original families. In addition to metacarpal brachydactyly (BDE), both ours and Johnson\'s patients had clinodactyly, deviations, and contractions of fingers, short thumbs with apparently hypoplastic distal phalanges, and hypoplastic middle and distal phalanges, especially of the little fingers. Unlike Johnson\'s families, none of our patients showed syndactyly of 3/4, ring finger duplication or long distal digit phalanges. Moreover, metacarpal brachydactyly in our case was confined solely to V^th^digits, whereas in other BDE patients also affected other rays \[[@B1],[@B2]\].

The mutant HOXD13 protein (p.R274X) synthesized in our proband is predicted to lack the entire homeodomain and hence cannot bind to DNA consensus. Likewise, the same pathogenic mechanism most probably exists in the case of p.E181X variant which also results in isolated BDE (see Figure [2](#F2){ref-type="fig"}). On the other hand, the most terminal of all known truncating *HOXD13*mutation (p.R319X), which is localized at the very end of the homeodomain sequence, produces SPD. Out of truncating *HOXD13*alterations, four frameshift and one splicing mutation have been additionally described in the literature. Four of them caused a phenotype referred to as \"SPD with foot anomalies\" (MIM\#186000), in which classic SPD was accompanied by supernumerary digit between I^st^-II^nd^and often IV^th^-V^th^metatarsals \[[@B16],[@B17]\]. The most plausible mechanism through which all truncating mutations exert their pathogenic effect is functional haploinsufficiency of *HOXD13*. Conversely, missense substitutions affecting different residues of homeodomain alter rather than abolish DNA binding ability of the mutant protein. Hence, mixed both gain- and loss-of-function mechanisms have been postulated to account for different limb phenotypes associated with these mutations \[[@B2],[@B6]\]. Despite different mutational mechanisms of p.I314L and p.S308C substitutions in reference to our mutation (p.R274X), there has been a substantial overlap in the clinical phenotype. More severe presentation associated with missense mutations can be thus explained by their dominant-negative effect.

Another example of a homeotic gene known from its pleiotropic pathogenic effect is a *HOXD13*paralogue belonging to a HOXA cluster-*HOXA13*. Mutations in this gene may give rise to different phenotypes, depending on their type and intragenic location. While nonsense truncating mutations N-terminal to or within the homeodomain, as well as expansions of polyalanine tract cause Hand-foot-genital syndrome (HFGS also known as Hand-foot-uterus syndrome; HFUS; MIM\#140000), missense mutation within the homeodomain has been associated with Guttmacher syndrome (MIM \#176305), a phenotype in which HFGS features are accompanied with postaxial polydactyly of the hands and uniphalangeal second toes \[[@B19],[@B20]\].

In the developmental context, *Hoxd13*has been shown to suppress chondrogenesis in the interdigital space, thus being responsible for proper digit formation. A loss-of-function mutation in mouse *Hoxd13*results in down-regulation of *Raldh2*and thereby in low tissue concentration of retinoic acid. This induces expression of *Sox9*in the interdigital mesenchyme, the formation of interdigital condensation, and consequently, polydactyly \[[@B21]\]. Conversely, missense mutations of human *HOXD13*localized in the homeodomain exert their pathogenicity via gain-of-function effect that possibly reduces level of *SOX9*expression. Of note, *Sox9*is also a target molecule of *Pthlh*(*Pthrp*) signaling in prehypertrophic chondrocytes in the growth plate. *Pthlh*increases transcriptional activity of *Sox9*, helps to maintain chondrocyte phenotype of the cells in the prehypertrophic zone, and inhibits their differentiation to hypertrophic chondrocytes \[[@B22]\]. Hence, haploinsufficiency of human *PTHLH*in BDE patients may at least partly result in reduced transcriptional activity of *SOX9*, which fails to maintain the chondrocyte phenotype in prehypertrophic zone and, in turn, promotes their maturation to hypertrophic chondrocytes.

Conclusions
===========

Isolated BDE can be caused by either *HOXD13*nonsense mutations or missense substitutions within the homeodomain of the HOXD13 transcription factor. *HOXD13*is a pleiotropic gene associated with various limb malformations. Most of the mutations occurring within the gene produce SPD, and not BDE.
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